Skip to content
← Full study record

NCT01118013 · MORE INFO

Limitations, agreements, and source contact

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant · Source last updated 2017-03-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
abashey@bmtga.com
organization
Blood and Marrow Transplant Group of Georgia
title
Asad Bashey, MD, PhD
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
abashey@bmtga.com
organization
Blood and Marrow Transplant Group of Georgia
title
Asad Bashey, MD, PhD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice